coronavirus treatment Archives | Be Korea-savvy
Celltrion’s COVID-19 Antibody Treatment Wins Temporary Approval in Switzerland

Celltrion’s COVID-19 Antibody Treatment Wins Temporary Approval in Switzerland

SEOUL, Jan. 14 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc. said Friday its COVID-19 antibody treatment has won temporary approval from Swedish authorities. Swissmedic granted Temporary Authorization of Rekirona for adult COVID-19 patients who do not require supplementary oxygen treatment and are at high risk of developing into severe cases. The approval will [...]

Celltrion’s COVID-19 Antibody Treatment Wins Emergency Approval in Australia

Celltrion’s COVID-19 Antibody Treatment Wins Emergency Approval in Australia

SEOUL, Dec. 7 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc. said Tuesday its COVID-19 antibody treatment has won emergency approval from Australian authorities. The Therapeutic Goods Administration (TGA) granted provisional approval of Rekirona for the intravenous treatment of mild-to-moderate COVID-19 in adult patients. It is the fifth COVID-19 treatment to receive regulatory approval [...]

Celltrion’s COVID-19 Antibody Treatment Shows Efficacy in Phase 3 Trial

Celltrion’s COVID-19 Antibody Treatment Shows Efficacy in Phase 3 Trial

SEOUL, June 14 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc. said Monday that its COVID-19 antibody treatment has sharply reduced recovery time and the chance of a severe case. Celltrion announced top-line results from a global phase three clinical study of Rekirona, a pivotal part of the study to obtain more comprehensive safety [...]

Celltrion Begins Developing COVID-19 Cocktail Treatment to Tackle Variants

Celltrion Begins Developing COVID-19 Cocktail Treatment to Tackle Variants

SEOUL, Feb. 18 (Korea Bizwire) – Celltrion Inc. said Thursday that its anti-COVID-19 monoclonal antibody treatment has confirmed neutralizing potency against the British variant, and the South Korean pharmaceutical giant has also begun developing a neutralizing antibody cocktail treatment. CT-P59, an anti-COVID-19 monoclonal antibody treatment, won the country’s drug safety agency’s conditional approval earlier this [...]

Celltrion Begins Supplying COVID-19 Antibody Treatment

Celltrion Begins Supplying COVID-19 Antibody Treatment

SEOUL, Feb. 17 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc. began supplying its COVID-19 antibody treatment to medical institutions in the country Wednesday. CT-P59 won the drug safety agency’s conditional approval earlier this month, becoming the first locally made treatment for COVID-19. CT-P59 will be administered to COVID-19 patients at higher risk, referring [...]

Celltrion to Conduct Additional Phase 1 Trial for Coronavirus Treatment

Celltrion to Conduct Additional Phase 1 Trial for Coronavirus Treatment

SEOUL, Aug. 26 (Korea Bizwire) — Celltrion Inc., a leading pharmaceutical firm in South Korea, said Wednesday that it will conduct an additional phase one clinical trial of its coronavirus treatment on patients. Celltrion’s CT-P59 will be administered to nine COVID-19 patients with mild symptoms to evaluate the safety and efficacy of the antiviral antibody [...]